News in Brief

Abzena remodels ADC facility in Pennsylvania

By Staff Reporter

- Last updated on GMT

GettyImages/klenger
GettyImages/klenger
Abzena has equipped its $5m Pennsylvania bioconjugation suite with Sartoius and GE Healthcare single-use equipment.

The $5m (€4m) investment at the firm’s site in Bristol, Pennsylvania – added when Abzena acquired The Chemistry Research Solution in 2015​​ – was announced last year​, and this week the firm said facility remodelling for the GMP manufacturing suite has been completed.

Empty space in the building is set to provide capacity for antibody-drug conjugation (ADC) services, and will allow Abzena to expand its process chemistry capabilities, including HPAPI process chemistry.

The remodelling was carried out by local contractors in Bristol, an Abzena spokesperson told Biopharma-Reporter, and the suite is scheduled for completion around the end of the second quarter of 2018.

We were told: The facility is equipped with Sartorius Levmixer, FlexAct & AlphaPlus and GE Akta single-use process equipment.”

Related news

Show more

Related products

show more

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 22-Jul-2019 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

Related suppliers

Follow us

Products

View more

Webinars